Bioservo Technologies AB Interim Report January – September 2018
Third quarter in figures · Net sales rose to SEK 1.0 M (0.5) · EBITDA amounted to SEK -5.8 M (-3.9) · EBIT totalled SEK -6.7 M (-4.5) · Loss for the period was SEK -6.7 M (-4.6) · Loss per share before and after dilution amounted to SEK -0.75 (-0.51) · At 30 September, cash and cash equivalents were SEK 32.1 M (55.0). First nine months in figures · Net sales rose to SEK 4.0 M (2.1) · EBITDA amounted to SEK -14.9 M (-11.2) · EBIT totalled SEK -17.2 M (-12.6) · Loss for the period was SEK -17.2 M (-13.5) · Loss per share before and